Docoh
Loading...

WST West Pharmaceutical Services

West Pharmaceutical Services, Inc. manufactures and markets pharmaceuticals, biologics, vaccines and consumer healthcare products. It operates through the following business segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers proprietary packaging, containment and drug delivery products, along with analytical lab services, to biologic, generic and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business, focused on the design, manufacture and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. The company was founded by Herman O. West on July 27, 1923 and is headquartered in Exton, PA.

Company profile

Ticker
WST
Exchange
CEO
Eric Green
Employees
Incorporated
Location
Fiscal year end
Former names
WEST CO INC
SEC CIK
IRS number
231210010

WST stock data

(
)

Calendar

23 Feb 21
12 Apr 21
31 Dec 21
Quarter (USD)
Dec 20 Sep 20 Jun 20 Mar 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Dec 20 Dec 19 Dec 18 Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
12 Mar 21 Chad Winters Common Stock Grant Aquire A No No 261.62 170 44.48K 714.887
26 Feb 21 Silji Abraham Common Stock Payment of exercise Dispose F No No 280.65 677 190K 8,248.3
23 Feb 21 Silji Abraham Stock Options Common Stock Grant Aquire A No No 274.29 4,364 1.2M 4,364
23 Feb 21 Favorite Annette F Stock Options Common Stock Grant Aquire A No No 274.29 3,968 1.09M 3,968
23 Feb 21 Quintin J Lai Stock Options Common Stock Grant Aquire A No No 274.29 2,776 761.43K 2,776

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

93.1% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 576 561 +2.7%
Opened positions 84 100 -16.0%
Closed positions 69 50 +38.0%
Increased positions 233 193 +20.7%
Reduced positions 191 207 -7.7%
13F shares
Current Prev Q Change
Total value 19.47B 18.55B +5.0%
Total shares 68.74M 67.55M +1.8%
Total puts 72.2K 25K +188.8%
Total calls 59.5K 72.7K -18.2%
Total put/call ratio 1.2 0.3 +252.9%
Largest owners
Shares Value Change
Vanguard 8.29M $2.35B -3.7%
BLK Blackrock 7.29M $2.07B +5.1%
TROW T. Rowe Price 4.62M $1.31B +3.9%
BEN Franklin Resources 3.85M $1.09B -1.7%
STT State Street 3.35M $948.3M -3.8%
IVZ Invesco 1.73M $488.97M +12.4%
ATAC Neuberger Berman 1.64M $464.52M -14.4%
WCM Investment Management 1.61M $457.08M +17.5%
Bamco 1.34M $378.24M -7.2%
Artisan Partners Limited Partnership 1.3M $368.6M -4.2%
Largest transactions
Shares Bought/sold Change
Norges Bank 745.96K +745.96K NEW
APG Asset Management 1.19M +680.09K +133.2%
1832 Asset Management 0 -482.2K EXIT
FMR 1.18M +376.26K +46.9%
BLK Blackrock 7.29M +350.91K +5.1%
Vanguard 8.29M -317.92K -3.7%
ATAC Neuberger Berman 1.64M -277.34K -14.4%
WCM Investment Management 1.61M +240.41K +17.5%
Carillon Tower Advisers 202.15K +202.15K NEW
Brown Advisory 1.17M +196.95K +20.2%

Financial report summary

?
Competition
Insulet
Management Discussion
  • Consolidated net sales increased by $307.0 million, or 16.7%, in 2020, including a favorable foreign currency translation impact of $5.7 million. Excluding foreign currency translation effects, as well as incremental sales of $1.2 million from the acquisition of our distributor in South Korea in 2019, consolidated net sales increased by $300.1 million, or 16.3%.
  • Proprietary Products – Proprietary Products net sales increased by $250.0 million, or 17.9%, in 2020, including a favorable foreign currency translation impact of $2.2 million. Excluding foreign currency translation effects, as well as $1.2 million of incremental sales in 2020 from the acquisition of our distributor in South Korea in 2019, net sales increased by $246.6 million, or 17.6%, primarily due to growth in our high-value product offerings, including our FluroTec-coated components, Westar® components, Daikyo® and NovaPure® components, Daikyo Crystal Zenith® products, and our self-injection delivery platforms, all of which included approximately $99 million in COVID-19 related activity for vaccines, antiviral treatments and treatment of underlying COVID-19 symptoms.
  • Contract-Manufactured Products – Contract-Manufactured Products net sales increased by $57.1 million, or 12.9%, in 2020, including a favorable foreign currency translation impact of $3.5 million. Excluding foreign currency translation effects, net sales increased by $53.5 million, or 12.1%, due to an increase in the sale of healthcare-related injection and diagnostic devices.
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. freshman Avg
New words: abuse, admixture, aforesaid, Amneal, antiviral, attrition, AZ, Bangalore, catalog, Cayey, centrally, Chad, CODM, collaborative, color, compel, consulting, convinced, Council, dedicated, diligence, distancing, downside, driven, duration, employment, England, ethical, facilitate, FCA, fluid, foster, found, gender, gowning, guide, HSE, imposed, improper, inclusion, inclusive, India, inspection, job, Kimberly, learning, lifetime, linking, live, MacKay, Maker, mask, matrix, member, mental, metric, mission, notably, online, optimize, organizational, partnership, percent, persuade, phase, Phoenix, precautionary, premium, proactive, progression, proud, receipt, remote, resource, reward, Scottsdale, screening, Segal, situation, slightly, specialty, spread, stronger, strongly, submit, tracked, trained, training, tuition, UGI, unforeseeable, upside, vision, women, workplace
Removed: absolute, achieving, Affordable, AG, backlog, began, Bolivar, Commonwealth, confirmation, consist, curtailment, deconsolidation, derecognition, discrete, division, dual, Eastman, expand, faulty, filled, George, governed, half, immaterial, Ireland, Kodak, leasing, making, Manager, mandatory, mechanism, methodology, Miller, mistake, nonfinancial, official, Ortho, party, positively, PPACA, previously, referendum, renew, rental, repeal, Resnick, seasonal, simple, spending, Sri, streamlined, substantially, Tech, termination, translating, Venezuela, Venezuelan, volume, Waterford

Patents

GRANT
Utility
Apparatuses for securing components of a drug delivery system during transport and methods of using same
30 Mar 21
An assembly of a drug delivery system, comprising: a first component; a second component which is configured to move linearly with respect to the first component; and, a resistance element configured to resist linear movement during transport of the first component with respect to the second component in a closed transport configuration but which is adapted to be overcome during nominal operation of the drug delivery system.
APP
Utility
Elastomer Articles Having Embedded Electronics and Method of Manufacturing the Same
25 Mar 21
A method of manufacturing a medical component includes preparing a first sheet of an elastomeric material, arranging at least one electronic device in the first sheet of elastomeric material to obtain an elastomeric preform, and arranging the elastomeric preform in a mold and molding the elastomeric preform therein to cure the elastomeric material and form the medical component having the at least one electronic device embedded therein.
GRANT
Utility
User actuated liquid drug transfer devices for use in ready-to-use (RTU) liquid drug transfer assemblages
16 Mar 21
Liquid drug transfer device for use in a Ready-To-Use liquid drug transfer assemblage for establishing flow communication between a liquid source and an injection vial.
GRANT
Utility
Detection and communication of plunger position using induction
16 Mar 21
A syringe system, including a plunger, a microcontroller, a battery, and a coil.
GRANT
Utility
Noise and vibration dampening mounting module for injector
23 Feb 21
An independent mounting module is receivable within a housing of an injector configured to dispense a substance from a cartridge insertable into the housing through an injection needle of the injector.